Hap Trading, LLC Horizon Therapeutics Public LTD CO Put Options Transaction History

Hap Trading, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 09, 2023	SELL	$98.98 - $115.74 $9.62 Million - $11.2 Million	-97,200 Reduced 6.06%	1,506,400 $174 Million
Q2 2023 Aug 11, 2023	BUY	$96.34 - $112.38 $146 Million - $171 Million	1,518,600 Added 1786.59%	1,603,600 $165 Million
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $94.7 Million - $100 Million	-882,000 Reduced 91.21%	85,000 $79,000
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $60.3 Million - $110 Million	967,000 New	967,000 $9,000
Q2 2022 Aug 12, 2022	SELL	$79.4 - $116.36 $262,020 - $383,988	-3,300 Reduced 15.71%	17,700 $280,000
Q1 2022 May 12, 2022	BUY	$86.42 - $109.81 $129,630 - $164,715	1,500 Added 7.69%	21,000 $210,000
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $660,352 - $803,397	6,700 Added 52.34%	19,500 $236,000
Q3 2021 Nov 10, 2021	BUY	$91.91 - $110.37 $1.18 Million - $1.41 Million	12,800 New	12,800 $119,000
Q2 2021 Aug 11, 2021	SELL	$86.24 - $95.92 $17.9 Million - $19.9 Million	-207,400 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $244,222 - $324,632	-3,400 Reduced 1.61%	207,400 $417,000
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $14.1 Million - $17.8 Million	210,800 New	210,800 $887,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.